Anna Maria Barbieri

7PUBLICATIONS
44CO-AUTHORS
Predictive and prognostic markersMolecular targetsInstruments and techniquesCancer geneticsDental therapeutics, pharmacology and toxicology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 15, 2026
Prevalence of somatic SF3B1R625H mutation in lactotroph tumours from a multi-centric cohort: a digital PCR-based study.

|Nov 11, 2024
Therapeutic potential of targeting the FLNA-regulated Wee1 kinase in adrenocortical carcinomas.

Emanuela Esposito, Giusy Marra, Rosa Catalano

|Apr 13, 2024
The Novel SSTR3 Agonist ITF2984 Exerts Antimitotic and Proapoptotic Effects in Human Non-Functioning Pituitary Neuroendocrine Tumor (NF-PitNET) Cells.

Genesio Di Muro, Rosa Catalano, Donatella Treppiedi

|Jun 28, 2023
A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells.

Genesio Di Muro, Federica Mangili, Emanuela Esposito

|May 28, 2022
P720R USP8 Mutation Is Associated with a Better Responsiveness to Pasireotide in ACTH-Secreting PitNETs.

Donatella Treppiedi, Giusy Marra, Genesio Di Muro

|Aug 27, 2021
Genetic Profiling of a Cohort of Italian Patients with ACTH-Secreting Pituitary Tumors and Characterization of a Novel <i>USP8</i> Gene Variant.

Donatella Treppiedi, Anna Maria Barbieri, Genesio Di Muro

Pageof 2

Frequent Collaborators

6 joint publications

Erika Peverelli

4 joint publications

Federica Mangili

4 joint publications

Giovanna Mantovani

3 joint publications

Maura Arosio